Robocore Temi Secures $30M Series D for Global Telemedicine Robotics

Hong Kong-based Robocore Technology Limited secured $30 million in Series D funding. Foxconn Technology Co., Ltd. (FTC) led the investment through its subsidiary Q-Run Holdings Limited. This capital supports Robocore's global telemedicine expansion.

Q-Run Holdings invested in Robocore's fully-owned subsidiary, RoboTemi Global Ltd, previously known as Temi. The initial $10 million tranche for a 6.6 percent equity stake is complete. Two additional $10 million tranches are possible on the first and second anniversaries. Foxconn's investment marks its formal entry into the smart robotics business, furthering its expansion into AI robotics and smart manufacturing.

Fueling Global Telemedicine and Robotics Growth

Robocore plans to build out its telemedicine services in the US, Europe, and Japan. The company will also add new products to China's consumer market. Furthermore, it aims to expand global sales and marketing efforts. Robocore's open-platform service robotics differentiate it from specialized industrial robot developers like Boston Dynamics.

Robocore operates as the world's leading open-platform service robotics business. Its Temi robots are installed in nearly 20,000 locations worldwide, including hospitals and elderly homes. Over 200 New York elderly homes utilize Temi robots for remote medical diagnoses. This technology reduces insurance expenditure and improves care quality, positioning Robocore alongside healthcare technology providers such as Teladoc Health.

The company prepares for a potential IPO by 2030.